1. Home
  2. RDW vs KYMR Comparison

RDW vs KYMR Comparison

Compare RDW & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$7.36

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$89.53

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
KYMR
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
4.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RDW
KYMR
Price
$7.36
$89.53
Analyst Decision
Buy
Strong Buy
Analyst Count
6
23
Target Price
$12.67
$101.43
AVG Volume (30 Days)
7.5M
1.4M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,147,000.00
$43,735,000.00
Revenue This Year
$11.89
$20.81
Revenue Next Year
$43.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$19.45
52 Week High
$26.66
$103.00

Technical Indicators

Market Signals
Indicator
RDW
KYMR
Relative Strength Index (RSI) 61.14 72.51
Support Level $5.11 $86.23
Resistance Level $5.58 $93.82
Average True Range (ATR) 0.50 4.66
MACD 0.34 2.34
Stochastic Oscillator 72.82 65.66

Price Performance

Historical Comparison
RDW
KYMR

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: